These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

624 related items for PubMed ID: 17070899

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Transforming growth factor-beta1-dependent activation of Smad2/3 and up-regulation of PAI-1 expression is negatively regulated by Src in SKOV-3 human ovarian cancer cells.
    Wakahara K, Kobayashi H, Yagyu T, Matsuzaki H, Kondo T, Kurita N, Sekino H, Inagaki K, Suzuki M, Kanayama N, Terao T.
    J Cell Biochem; 2004 Oct 15; 93(3):437-53. PubMed ID: 15372629
    [Abstract] [Full Text] [Related]

  • 3. Wound-induced migration of MDA-MB-435 and SKOV-3 cancer cells is regulated by plasminogen activator inhibitor-1.
    Whitley BR, Church FC.
    Int J Oncol; 2005 Sep 15; 27(3):749-57. PubMed ID: 16077925
    [Abstract] [Full Text] [Related]

  • 4. Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase.
    Dunn SE, Torres JV, Oh JS, Cykert DM, Barrett JC.
    Cancer Res; 2001 Feb 15; 61(4):1367-74. PubMed ID: 11245436
    [Abstract] [Full Text] [Related]

  • 5. Phosphatidylinositol 3-kinase/protein kinase Akt negatively regulates plasminogen activator inhibitor type 1 expression in vascular endothelial cells.
    Mukai Y, Wang CY, Rikitake Y, Liao JK.
    Am J Physiol Heart Circ Physiol; 2007 Apr 15; 292(4):H1937-42. PubMed ID: 17172275
    [Abstract] [Full Text] [Related]

  • 6. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
    Nicholl SM, Roztocil E, Davies MG.
    J Vasc Surg; 2005 Apr 15; 41(4):672-81. PubMed ID: 15874933
    [Abstract] [Full Text] [Related]

  • 7. Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells.
    Das R, Mahabeleshwar GH, Kundu GC.
    J Biol Chem; 2003 Aug 01; 278(31):28593-606. PubMed ID: 12771144
    [Abstract] [Full Text] [Related]

  • 8. Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer.
    Hua K, Feng W, Cao Q, Zhou X, Lu X, Feng Y.
    Int J Oncol; 2008 Nov 01; 33(5):959-67. PubMed ID: 18949358
    [Abstract] [Full Text] [Related]

  • 9. Expression of urokinase plasminogen activator and plasminogen activator inhibitor type-1 in ovarian cancer and its clinical significance.
    Zhang W, Ling D, Tan J, Zhang J, Li L.
    Oncol Rep; 2013 Feb 01; 29(2):637-45. PubMed ID: 23174953
    [Abstract] [Full Text] [Related]

  • 10. Gonadotropins activate proteolysis and increase invasion through protein kinase A and phosphatidylinositol 3-kinase pathways in human epithelial ovarian cancer cells.
    Choi JH, Choi KC, Auersperg N, Leung PC.
    Cancer Res; 2006 Apr 01; 66(7):3912-20. PubMed ID: 16585220
    [Abstract] [Full Text] [Related]

  • 11. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
    Das R, Philip S, Mahabeleshwar GH, Bulbule A, Kundu GC.
    IUBMB Life; 2005 Jun 01; 57(6):441-7. PubMed ID: 16012053
    [Abstract] [Full Text] [Related]

  • 12. Association of urokinase-type plasminogen activator and its inhibitor with disease progression and prognosis in ovarian cancer.
    Konecny G, Untch M, Pihan A, Kimmig R, Gropp M, Stieber P, Hepp H, Slamon D, Pegram M.
    Clin Cancer Res; 2001 Jun 01; 7(6):1743-9. PubMed ID: 11410515
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.
    Zhou C, Qiu L, Sun Y, Healey S, Wanebo H, Kouttab N, Di W, Yan B, Wan Y.
    Int J Oncol; 2006 Jul 01; 29(1):269-78. PubMed ID: 16773209
    [Abstract] [Full Text] [Related]

  • 14. RhoA/ROCK pathway mediates leptin-induced uPA expression to promote cell invasion in ovarian cancer cells.
    Ghasemi A, Hashemy SI, Aghaei M, Panjehpour M.
    Cell Signal; 2017 Apr 01; 32():104-114. PubMed ID: 28104444
    [Abstract] [Full Text] [Related]

  • 15. (-)-Epigallocatechin gallate derivatives reduce the expression of both urokinase plasminogen activator and plasminogen activator inhibitor-1 to inhibit migration, adhesion, and invasion of MDA-MB-231 cells.
    Shin S, Kim MK, Jung W, Chong Y.
    Phytother Res; 2018 Oct 01; 32(10):2086-2096. PubMed ID: 30009577
    [Abstract] [Full Text] [Related]

  • 16. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
    Shukla S, Maclennan GT, Hartman DJ, Fu P, Resnick MI, Gupta S.
    Int J Cancer; 2007 Oct 01; 121(7):1424-32. PubMed ID: 17551921
    [Abstract] [Full Text] [Related]

  • 17. Critical involvement of ILK in TGFbeta1-stimulated invasion/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system.
    Lin SW, Ke FC, Hsiao PW, Lee PP, Lee MT, Hwang JJ.
    Exp Cell Res; 2007 Feb 01; 313(3):602-13. PubMed ID: 17187779
    [Abstract] [Full Text] [Related]

  • 18. Stromal cell-derived factor-1 (SDF-1) enhances cells invasion by αvβ6 integrin-mediated signaling in ovarian cancer.
    Xue B, Wu W, Huang K, Xie T, Xu X, Zhang H, Qi C, Ge J, Yu Y.
    Mol Cell Biochem; 2013 Aug 01; 380(1-2):177-84. PubMed ID: 23615713
    [Abstract] [Full Text] [Related]

  • 19. Expression of active plasminogen activator inhibitor-1 reduces cell migration and invasion in breast and gynecological cancer cells.
    Whitley BR, Palmieri D, Twerdi CD, Church FC.
    Exp Cell Res; 2004 Jun 10; 296(2):151-62. PubMed ID: 15149846
    [Abstract] [Full Text] [Related]

  • 20. Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells.
    Chandrasekar N, Mohanam S, Gujrati M, Olivero WC, Dinh DH, Rao JS.
    Oncogene; 2003 Jan 23; 22(3):392-400. PubMed ID: 12545160
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.